A Randomized Phase 2 Study of Paclitaxel and Carboplatin with or without Conatumumab for First-Line Treatment of Advanced Non–Small-Cell Lung Cancer

Luis Paz-Ares, Beatrix Bálint, Richard H. de Boer, Jan P. van Meerbeeck, Rafal Wierzbicki, Paul De Souza, Francesco Galimi, Vincent Haddad, Tony Sabin, Yong-jiang Hei, Yang Pan, Susan Cottrell (+2 others)
2013 Journal of Thoracic Oncology  
doi:10.1097/jto.0b013e31827ce554 pmid:23370314 fatcat:g3rdu7kq65bkffxl2eprxgh2kq